Serum IgG levels and specific antibody titers against infectious agents (haemophilus influenzae, pneumococcus) or toxins (tetanus and diphtheria) were not affected by the therapy [193], resembling the clinical observation of anti-CD19 CAR-T in treating SLE [190]. The gene discussed is CD19; the disease is systemic lupus erythematosus.